Skip to the comparison

Independent review

NewSelf review: GLP‑1 pricing and terms

4.5/5

Trustpilot, 3,909 reviews, read 19 Oct 2026

What you pay

$99.97 medication and care

$99.97/mo

no membership fee, and we checked

✓ Verified 16 Nov 2026

First year

$1,199.64–$1,733.88 cheapest to most expensive product

Cancellation

Published terms are unclear

NewSelf's own site, not a paid placement

The price receipt

What makes up the total

Medication / month
$99.97
Membership / month
$0
Due upfront
$99.97

Billed monthly, no commitment stated

Price verified ✓ Price checked

8.6/10 VerifiedDose score How we score this →

What NewSelf charges, read from its own pages on 16 Nov 2026.

  • Every dose priced
  • No membership fee

What each plan costs

  • SemaglutideCompounded $99.97
  • TirzepatideCompounded $144.49

Compounded medications are not FDA-approved: "Compounded drugs are not approved by FDA" (FDA, page current as of 1 Apr 2026, read 14 Oct 2026 (opens in a new tab)).

✓ Prices checked 16 Nov 2026

What stands out

  • Dose pricing Every dose priced
  • Insurance Insurance filing not recorded
  • Regulatory record FDA warning letter, Feb 2026
  • Legal entity Legal entity published
  • Cancellation Cancellation terms not published

At its lowest dated price, NewSelf costs $99.97 a month, with no membership fee on top, checked 16 Nov 2026.

NewSelf sells compounded semaglutide and tirzepatide, states on its own site that there is no dosage upcharge, and carries a membership fee we checked and recorded at zero. Its record also carries an FDA warning letter, so read that beside the pricing rather than after it.

Verdict: NewSelf is worth a look if you want a compounded plan the company says costs the same at every dose, and whose membership fee we checked and recorded at zero. Read the record first. FDA issued a warning letter to NewSelf Limited in February 2026 for false and misleading claims. A rating does not answer it.

  • Membership fee checked at zero, so the plan figure is what we found rather than a base charge with a fee on top.
  • Publishes a pricing schedule, which most of the providers we track do not.
  • Names its legal entity, NewSelf Limited LLC, so the brand is traceable to a registered company.
  • Both plans bill monthly rather than as a prepaid term, and its semaglutide listing covers a band of doses at a single figure.

Quick facts

Medications
Semaglutide, Tirzepatide
Regulatory record
FDA letter, Feb 2026
Price history

How much does NewSelf cost?

At its lowest dated price, NewSelf costs $99.97 a month, with no membership fee on top, checked 16 Nov 2026.

Price changes appear in the change log.

NewSelf plans. 2 plans, cash price per billing cycle with the date each price was verified.
Plan Medication Price
Semaglutide, 0.25-2.0 mg Injection Compounded $99.97 Price verified ✓ Price checked
Tirzepatide, Tirzepatide+ Injection Compounded $144.49 Price verified ✓ Price checked

How much is compounded semaglutide at NewSelf?

Compounded semaglutide at NewSelf starts at $99.97 a month, with no membership fee on top, checked 16 Nov 2026.

How much is compounded tirzepatide at NewSelf?

Compounded tirzepatide at NewSelf starts at $144.49 a month, with no membership fee on top, checked 16 Nov 2026.

Where NewSelf sits in our price rankings: 2nd of 38 in Cheapest GLP-1 telehealth · 2nd of 34 in Best tirzepatide telehealth by price · 2nd of 13 in Cheapest GLP-1 without membership. Each ranking groups providers by how they bill and whether we know their fee, then orders each group by what a year costs at the verified price.

What Tirzepatide costs across every channel we track is in our Tirzepatide price guide. What Semaglutide costs across every channel we track is in our Semaglutide price guide.

No membership fee and no dosage upcharge. One price at every dose. HSA/FSA accepted where the provider states it; we have not established whether insurance is billed.

Where it falls short

NewSelf's pricing is the most legible thing about it, and it is also the thing we could only half check. The company says there is no dosage upcharge and one price at every dose. Its semaglutide listing supports that, because the row covers a band of doses at a single figure. Its tirzepatide listing names no band at all, so on that product the statement has nothing behind it. Separately, the record carries an FDA warning letter from February 2026, and a membership fee checked at zero does not change that.

  • FDA issued a warning letter to NewSelf Limited dba NewSelf in February 2026 for false and misleading claims and misbranding. Cited to the FDA's own record on this page.
  • The no-upcharge statement is the company's and not our finding, and its tirzepatide listing names no dose band, so on that product there is nothing to check it against.
  • We could not establish whether it files insurance claims on your behalf.
  • Both plans are compounded preparations rather than the branded drug.

How NewSelf compares

More columns to the right. Drag or swipe the table.

NewSelf compared with 3 alternative providers.
Metric
VerifiedDose score 8.6 7.9 7.9 8.3
From checked the same day for all 4 $99.97 Price verified ✓ Price checked $149 Price verified ✓ Price checked $1,399 Price verified ✓ Price checked $60 Price verified ✓ Price checked
Insurance Not recorded Files claimsNot recordedFiles claims

How it works

NewSelf terms: what the provider states about its model, timing, insurance and cancellation.

Model
Hybrid
Membership fee
None ✓ checked 16 Nov 2026
Insurance
Not recorded
Time to prescription
Not stated
Cancellation
Not documented
States served
Not recorded
Refunds
Not recorded
VerifiedDose score
8.6/10. How we rate providers.

NewSelf reviews

Third-party aggregate, quoted not endorsed

4.5/5 on Trustpilot, from 3,909 reviews, read 19 Oct 2026

A lifetime average of reviews left on Trustpilot. It is not a measure of clinical care, and providers differ in when and how they ask for reviews.

See the profile on Trustpilot (opens in a new tab)

Is NewSelf legit? Its company and regulatory record

We don't certify companies; this is the record we hold for NewSelf. Legal entity on file: NewSelf Limited LLC. We hold 1 record on file for it, each with its source below; the latest is an FDA warning letter dated 20 Feb 2026.

We read its prices from its public pages; the latest reading is from 16 Nov 2026. Third-party reputation: Trustpilot 4.5 from 3,909 reviews, read 19 Oct 2026. Official domain: https://newself.com/.

Regulatory record

1 regulatory record on file

What has changed

  • First membership fee on record: none

    NewSelf not published → $0

    Observation and source

    Recorded here on 9 Aug 2026. This entry predates our observation log, so the day the provider's page changed is not on file.

  • Price decreased

    NewSelf $224.99 → $144.49

    Observation and source

    Seen on the provider's own page on 9 Aug 2026, recorded here on 9 Aug 2026.

    Tirzepatide Tirzepatide+, all dosages — read from the provider's own page on 09 Aug 2026.

    The page this was read from (opens in a new tab)
  • Price decreased

    NewSelf $224.99 → $144.49

    Observation and source

    Seen on the provider's own page on 9 Aug 2026, recorded here on 9 Aug 2026.

    Tirzepatide — verified 09 Aug 2026

    The page this was read from (opens in a new tab)
  • Price decreased

    NewSelf $134.99 → $99.97

    Observation and source

    Seen on the provider's own page on 9 Aug 2026, recorded here on 9 Aug 2026.

    Semaglutide Semaglutide+, all dosages — read from the provider's own page on 09 Aug 2026.

    The page this was read from (opens in a new tab)
  • Price decreased

    NewSelf $134.99 → $99.97

    Observation and source

    Seen on the provider's own page on 9 Aug 2026, recorded here on 9 Aug 2026.

    Semaglutide — verified 09 Aug 2026

    The page this was read from (opens in a new tab)
  • First price on record

    NewSelf $224.99

    Observation and source

    Seen on the provider's own page on 6 Aug 2026, recorded here on 9 Aug 2026.

    Tirzepatide Tirzepatide+ — read from the provider's own page on 06 Aug 2026.

    The page this was read from (opens in a new tab)
  • First price on record

    NewSelf $134.99

    Observation and source

    Seen on the provider's own page on 6 Aug 2026, recorded here on 9 Aug 2026.

    Semaglutide Semaglutide+ — read from the provider's own page on 06 Aug 2026.

    The page this was read from (opens in a new tab)
  • First price on record

    NewSelf not published → $134.99

    Observation and source

    Seen on the provider's own page on 6 Aug 2026, recorded here on 9 Aug 2026.

    Semaglutide — verified 06 Aug 2026

    The page this was read from (opens in a new tab)

What the price claim covers, and what it does not

NewSelf states on its own site that there is no membership fee and no dosage upcharge, and that one price covers every dose. We checked the fee ourselves and recorded a zero, so that half of the statement is our finding as well as theirs. The dose half is not. We have attributed it rather than verified it, and the table above shows how far it can be checked.

The semaglutide listing is the part that supports the claim. One row covers a band of doses at a single figure, which is the shape a flat price takes when a provider publishes one. The tirzepatide listing is the part that does not. It names a product and no dose band, so there is nothing on that row to hold the statement to. NewSelf publishes a pricing schedule, which most of the providers we track do not, and this is where that schedule stops.

NewSelf states on its site that its compounded plans carry no membership fee and no dosage upcharge, and that one price applies at every dose.

NewSelf pricing page 1 Oct 2026 Primary source (opens in a new tab)

The record

NewSelf's pricing is legible and its record is not clean. Those are two separate findings about the same company, and the second one does not go away because the first one is good. FDA wrote to NewSelf Limited in February 2026. A warning letter is a regulator acting, not a court judgment and not a recall, and the wording below is the agency's rather than ours. The rating on this page measures a third thing again, which is what buyers said about their orders. Three measurements, and none of them settles the other two.

FDA issued a warning letter to NewSelf Limited dba NewSelf for false and misleading claims and misbranding in connection with telehealth marketing.

FDA 20 Feb 2026 Primary source (opens in a new tab)

Questions readers ask

Does NewSelf charge the same at every dose?

NewSelf says so on its own site. Its semaglutide listing supports that, because one row covers a band of doses at a single figure. Its tirzepatide listing names no band, so on that product we have attributed the statement rather than verified it.

Does NewSelf charge a membership fee?

No. We checked it and recorded a zero, and the date we checked sits beside it on this page. The company says the same on its own pages.

Is NewSelf selling the branded drug?

No. Both of its plans are compounded preparations rather than the branded product. That is the only thing we assert about the drug itself.

Does NewSelf take insurance?

We could not establish it. Our record carries no entry either way, which means we did not confirm it and not that the answer is no.

Its rating is good and the pricing is clear. Why does the warning letter still lead the verdict?

Because the three are separate measurements. A rating is what buyers said, a price page is what the company publishes, and a warning letter is a regulator acting. We print all three and let none of them settle the others.

Where it prescribes

No state coverage on file for NewSelf. Nothing published

Sources

How this site works

How we rate providers

Verified price, first-year cost, availability, speed to prescription, cancellation terms, regulatory record. Methodology.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records.

How we make money

We may earn a referral fee from links on this page. Fees never influence ratings. Full disclosure.